Bicyclomycin fluorescent probes: Synthesis and biochemical, biophysical, and biological properties

被引:16
作者
Brogan, AP
Widger, WR [1 ]
Kohn, H
机构
[1] Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA
[2] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA
关键词
D O I
10.1021/jo030020u
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Bicyclomycin (1) is a commercially available antibiotic whose primary site of action in Escherichia coli is the transcription termination factor rho. Key aspects of the 1(.)rho interaction-K-d, stoichiometry for 1(.)rho binding, and whether 1 and ATP binding induce conformational changes in rho-remain unknown. In this study, the design, synthesis, and characterization of a series of bicyclomycin fluorescent probes (BFP) constructed to sense the 1(.)rho interaction are described and their use documented. We show that dihydrobicyclomycins with medium-to-large C(5a)-substituents afforded excellent inhibitory activities exceeding those of 1 in the poly(C)-dependent ATPase assay. The utility of BFP in hicyclomycin-rho binding studies was documented through the use of 5a(phenazin-2-ylmethylsulfanyl)dihydrobicyclomycin (15). Excitation (290 nm) of W381 in wild-type rho in the presence of 15 and ATP led to fluorescence resonance energy transfer (FRET) and gave a K-d (15) of 9.9 muM. Using ADP in place of ATP or excluding nucleotide did not result in energy transfer, which suggests that ATP binding induced a conformational change in rho. FRET measurements provided an approximate weighted average distance (23 A) between W381 and 15 in the presence of bound ATP. The Kd value for 15(.)rho was correlated with ATP binding at the 3 tight ATP binding (K-d(ATP) = 95 nM) sites in wild-type rho.
引用
收藏
页码:5575 / 5587
页数:13
相关论文
共 62 条
[1]   STRUCTURE AT 2.8-ANGSTROM RESOLUTION OF F1-ATPASE FROM BOVINE HEART-MITOCHONDRIA [J].
ABRAHAMS, JP ;
LESLIE, AGW ;
LUTTER, R ;
WALKER, JE .
NATURE, 1994, 370 (6491) :621-628
[2]   ESCHERICHIA-COLI TRANSCRIPTION TERMINATION FACTOR-P HAS A 2-DOMAIN STRUCTURE IN ITS ACTIVATED FORM [J].
BEAR, DG ;
ANDREWS, CL ;
SINGER, JD ;
MORGAN, WD ;
GRANT, RA ;
VONHIPPEL, PH ;
PLATT, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (07) :1911-1915
[3]  
Boyer PD, 1998, ANGEW CHEM INT EDIT, V37, P2297, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2296::AID-ANIE2296>3.0.CO
[4]  
2-W
[5]   Design, syntheses, and evaluations of bicyclomycin-based rho inactivators [J].
Cho, HJ ;
Park, HG ;
Zhang, XD ;
Riba, I ;
Gaskell, SJ ;
Widger, WR ;
Kohn, H .
JOURNAL OF ORGANIC CHEMISTRY, 1997, 62 (16) :5432-5440
[6]   ISOLATION AND CHARACTERIZATION OF CONDITIONAL LETHAL MUTANTS OF ESCHERICHIA-COLI DEFECTIVE IN TRANSCRIPTION TERMINATION FACTOR RHO [J].
DAS, A ;
COURT, D ;
ADHYA, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (06) :1959-1963
[7]  
DOLAN JW, 1990, J BIOL CHEM, V265, P5747
[8]  
DOMBROSKI AJ, 1988, J BIOL CHEM, V263, P18810
[9]   FACTORS DETERMINING NUCLEOPHILIC REACTIVITIES [J].
EDWARDS, JO ;
PEARSON, RG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1962, 84 (01) :16-&
[10]  
ERICSSON HM, 1971, ACTA PATHOLOG MICROB, P1